TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) IN CHRONIC PHASE (CP) - THE EFFECT OF AGE

被引：0
|
作者：
PETERSEN, FB [1 ]
CLIFT, RA [1 ]
BUCKNER, CD [1 ]
机构：
[1] SEATTLE MARROW TRANSPLANT TEAM,SEATTLE,WA
来源：
EXPERIMENTAL HEMATOLOGY | 1991年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [41] PHILADELPHIA-NEGATIVE (PH-) CHRONIC MYELOID-LEUKEMIA (CML) - COMPARISON WITH PH+ CML AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    MARTIAT, P
    MICHAUX, JL
    RODHAIN, J
    BLOOD, 1991, 78 (01) : 205 - 211
  • [42] OPTIMIZATION OF ANTISENSE OLIGODEOXYNUCLEOTIDE STRUCTURE FOR TARGETING CHRONIC MYELOID-LEUKEMIA (CML)
    CLARK, RE
    GILES, RV
    GREEN, JA
    TIDD, DM
    BLOOD, 1994, 84 (10) : A156 - A156
  • [43] THE SIGNIFICANCE OF PROMEGAKARYOBLASTS AND MICROMEGAKARYOCYTES FOR THE PROLIFERATION KINETICS IN CHRONIC MYELOID-LEUKEMIA (CML)
    RENNER, D
    DOLL, A
    QUEISSER, W
    BLUT, 1987, 55 (04): : 392 - 392
  • [44] CLINICOIMMUNOLOGICAL EFFECT OF TACTIVIN IN CHRONIC MYELOID-LEUKEMIA
    ABDULKADYROV, KM
    GUSEVA, SA
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1994, 39 (05): : 19 - 22
  • [45] Phase II Clinical Trial Results of Dasatinib for Frontline Therapy in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    O'Brien, Susan
    Borthakur, Gautam
    Ravandi, Farhad
    Verstovsek, Srdan
    Daver, Naval G.
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Skinner, Jeff
    Konopleva, Marina
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [46] Primary results of the phase 4 BYOND study of bosutinib (BOS) for pretreated chronic phase (CP) chronic myeloid leukemia (CML).
    Gambacorti-Passerini, Carlo
    Abboud, Camille N.
    Gjertsen, Bjorn T.
    Brummendorf, Tim H.
    Smith, B. Douglas
    Giraldo-Castellano, Pilar
    Olsson-Stromberg, Ulla
    Saussele, Susanne
    Bardy-Bouxin, Nathalie
    Viqueira, Andrea
    Leip, Eric
    Leone, Jocelyn M.
    Rosti, Gianantonio
    Watts, Justin M.
    Giles, Frank
    Hochhaus, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Phase II trial of dasatinib (DAS) in pediatric patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP).
    Gore, Lia
    Kearns, Pamela
    Lee, Maria Lucia
    De Souza, Carmino Antonio
    Bertrand, Yves
    Hijiya, Nobuko
    Stork, Linda C.
    Chung, Nack-Gyun
    Cardenas-Cardos, Rocio
    Saikia, Tapan
    Fagioli, Franca
    Seo, Jong-Jin
    Landman-Parker, Judith
    Lancaster, Donna
    Place, Andrew E.
    Rabin, Karen R.
    Sacchi, Mariana
    Swanink, Rene
    Zwaan, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] BCR BREAKPOINT AND PROGNOSIS OF CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA - RESPONSE
    MORRIS, SW
    HANCOCK, ML
    LEBOWITZ, P
    BLOOD, 1990, 76 (12) : 2637 - 2638
  • [49] BCL-2 EXPRESSION IN-VIVO IN ACUTE MYELOID-LEUKEMIA (AML), CHRONIC PHASE CML, AND MYELOID BLASTIC CRISIS OF CML
    PREISLER, HD
    HEGDE, U
    BLOOD, 1993, 82 (10) : A111 - A111
  • [50] CHRONIC MYELOID-LEUKEMIA - A PERSPECTIVE OF THE CLINICAL AND BIOLOGIC ISSUES OF THE CHRONIC PHASE
    SILVER, RT
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (02) : 319 - 335
12345